Your browser doesn't support javascript.
loading
Markov modeling for the neurosurgeon: a review of the literature and an introduction to cost-effectiveness research.
Wali, Arvin R; Brandel, Michael G; Santiago-Dieppa, David R; Rennert, Robert C; Steinberg, Jeffrey A; Hirshman, Brian R; Murphy, James D; Khalessi, Alexander A.
Afiliação
  • Wali AR; Department of Neurological Surgery and.
  • Brandel MG; Department of Neurological Surgery and.
  • Santiago-Dieppa DR; Department of Neurological Surgery and.
  • Rennert RC; Department of Neurological Surgery and.
  • Steinberg JA; Department of Neurological Surgery and.
  • Hirshman BR; Department of Neurological Surgery and.
  • Murphy JD; Radiation Medicine and Applied Sciences, University of California, San Diego, California.
  • Khalessi AA; Department of Neurological Surgery and.
Neurosurg Focus ; 44(5): E20, 2018 05.
Article em En | MEDLINE | ID: mdl-29712528
ABSTRACT
OBJECTIVE Markov modeling is a clinical research technique that allows competing medical strategies to be mathematically assessed in order to identify the optimal allocation of health care resources. The authors present a review of the recently published neurosurgical literature that employs Markov modeling and provide a conceptual framework with which to evaluate, critique, and apply the findings generated from health economics research. METHODS The PubMed online database was searched to identify neurosurgical literature published from January 2010 to December 2017 that had utilized Markov modeling for neurosurgical cost-effectiveness studies. Included articles were then assessed with regard to year of publication, subspecialty of neurosurgery, decision analytical techniques utilized, and source information for model inputs. RESULTS A total of 55 articles utilizing Markov models were identified across a broad range of neurosurgical subspecialties. Sixty-five percent of the papers were published within the past 3 years alone. The majority of models derived health transition probabilities, health utilities, and cost information from previously published studies or publicly available information. Only 62% of the studies incorporated indirect costs. Ninety-three percent of the studies performed a 1-way or 2-way sensitivity analysis, and 67% performed a probabilistic sensitivity analysis. A review of the conceptual framework of Markov modeling and an explanation of the different terminology and methodology are provided. CONCLUSIONS As neurosurgeons continue to innovate and identify novel treatment strategies for patients, Markov modeling will allow for better characterization of the impact of these interventions on a patient and societal level. The aim of this work is to equip the neurosurgical readership with the tools to better understand, critique, and apply findings produced from cost-effectiveness research.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cadeias de Markov / Análise Custo-Benefício / Tomada de Decisão Clínica / Neurocirurgiões Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cadeias de Markov / Análise Custo-Benefício / Tomada de Decisão Clínica / Neurocirurgiões Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article